Skopos Labs, Inc. Anavex Life Sciences Corp. Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Skopos Labs, Inc. holds 816 shares of AVXL stock, worth $8,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
816Holding current value
$8,559% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
161Shares Held
27.4MCall Options Held
515KPut Options Held
838K-
Black Rock Inc. New York, NY6.39MShares$67 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$49.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$32.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$19.8 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA910KShares$9.55 Million0.32% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $818M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...